This study is comparing two ways to monitor blood sugar during pregnancy for women with Type 2 diabetes: continuous glucose monitors (CGMs) and traditional finger-stick glucose monitoring. CGMs are sensors that automatically track blood sugar levels, while finger-stick monitoring involves pricking your finger to get a blood sample. The study wants to see if CGMs help patients stick to their monitoring schedule better. This is important because managing blood sugar during pregnancy can reduce risks like larger babies, low blood sugar in newborns, and high blood pressure for the mother. The study is looking for women aged 18 and older who have Type 2 diabetes, are pregnant with one baby, and started prenatal care before 20 weeks of pregnancy. The study's status is unclear.

Study design

This is an interventional study planning to enroll 70 women. It will compare adherence to glucose monitoring using continuous glucose monitors versus finger-stick monitoring.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Patient glucose monitoring adherence will be measured throughout the pregnancy, typically between 20-35 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.